论文信息 - Concomitant Use of Adalimumab and Immunomodulators Compared With Adalimumab Alone: Pooled Malignancy Safety Analysis: P‐23 - 字舞流文

Concomitant Use of Adalimumab and Immunomodulators Compared With Adalimumab Alone: Pooled Malignancy Safety Analysis: P‐23

J. Lewis | W. Sandborn | J. Colombel | R. Thakkar | P. Pollack | Bidan Huang | M. Osterman | A. Robinson | W. Lau